SCHEMBL289203

SCHEMBL289203

O=C(O)CNCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4018617 0.84
SCHEMBL6804037 0.84 ITGB1 (0.38)
SCHEMBL10988936 0.82 LMNA (0.44)
SCHEMBL163217 0.82 LMNA (0.44)
SCHEMBL262188 0.81
Water SCHEMBL4057424 0.79 LMNA (0.41)
SCHEMBL6343644 0.79 LMNA (0.41)
SCHEMBL1134677 0.79 LMNA (0.41)
SCHEMBL1684976 0.79 LMNA (0.41)
SCHEMBL18160753 0.79 LMNA (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112972395-B Capsule preparation and preparation method and application thereof 湖北舒邦药业有限公司 2022-12-13 CN claimed
CN-112972395-A Capsule preparation and preparation method and application thereof 湖北舒邦药业有限公司 2021-06-18 CN claimed
EP-2613762-B1 TOPICAL SKIN CARE FORMULATIONS COMPRISING JABOTICABA FRUIT PULP MARY KAY INC (US) 2018-10-17 EP claimed
US-20180201647-A1 Peptoid THE UNIVERSITY OF DURHAM (GB) 2018-07-19 US claimed
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2018-07-10 US claimed
EP-2836485-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2018-01-10 EP claimed
US-9695191-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2017-07-04 US claimed
EP-2499148-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2017-01-18 EP claimed
US-9512139-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2016-12-06 US claimed
CN-103442691-B Comprise the topical skin care preparation of Myrciaria cauliflora and cashew nut tree sarcocarp and extract thereof MARY KAY INC. (US) 2016-01-06 CN claimed
WO-2006037848-A1 METHOD AND PREPARATION FOR BINDING ALDEHYDES IN SALIVA BIOHIT OYJ (FI) 2006-04-13 WO claimed
US-7014844-B2 Lightening compositions and methods of use AVON PRODUCTS, INC. (US) 2006-03-21 US claimed
US-20050267042-A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine BIOHIT OYJ (FI) 2005-12-01 US claimed
WO-2005100385-A2 COMPOUNDS THAT BLOCK THE C5A RECEPTOR AND THEIR USE IN THERAPY ALLIGATOR BIOSCIENCE AB (PUBL) (SE) 2005-10-27 WO claimed
EP-1586583-A2 Compounds that block C5a complement receptor and their use in therapy Alligator Bioscience AB (publ) (SE) 2005-10-19 EP claimed
CN-1486177-A Method and formulation for binding acetaldehyde in saliva, stomach and large intestine ϣ�������ع����޹�˾ 2004-03-31 CN claimed
EP-1339394-A1 METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, STOMACH AND LARGE INTESTINE BIOHIT OYJ (FI) 2003-09-03 EP claimed
US-20030157202-A1 Tris-carboxylmethyl cysteamine as whitening agents to regulate melanin synthesis; cosmetics for skin treatment, reducing uneven pigmentation in the skin, skin disorders AVON PRODUCTS, INC. 2003-08-21 US claimed
WO-2003006048-A1 COMBINATION OF CHIPS (CHEMOTAXIS INHIBITING PROTEIN FROM STAPHYLOCOCCUS AUREUS)-BASED COMPOUNDS JARI PHARMACEUTICALS B.V. (NL) 2003-01-23 WO claimed
WO-2002036098-A1 METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, STOMACH AND LARGE INTESTINE LICENTIA LTD (FI) 2002-05-10 WO claimed